Aqualung Therapeutics Company
%20.jpg)
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
%20.jpg)
Headquarters:
Others
Total Funding:
$19.8M
Founded Date:
2010-01-01
Employee Number:
1-10
Last Funding Type:
Grant
Investors Number:
2
Technology:
Other
Industry:
P4 Medicine